🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Edwards Lifesciences Corporation

EW Healthcare
$91.6 $-0.96 (-1.04%)
Market Cap: $52.8 B
Gurus Holding
10
Popularity Rank
#506
% of Shares Held
0.69%
Net Activity (Q2 2026)
-$145.55 M

Guru Ownership Trend

Guru Analysis for Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Corporation (EW), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 10 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $362.18 M.

Top institutional holders include Steven Cohen and Cliff Asness.

Institutional sentiment is currently Bearish. This is evidenced by a $145.55 M net outflow during the quarter.

Recent activity highlights Jefferies Group who increased their stake by 73.3%. Conversely, Joel Greenblatt reduced exposure by 56.4%.

Key Holders

Top 5 by Value

$160.49 M
$132.17 M
$24.9 M
$14.94 M
$9.07 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$9.5 M
Total Buy Value
New Buys 0
Additions 3
-$155.05 M
Total Sell Value
Reductions 6
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
7
Net Buyers
3

FAQs for Edwards Lifesciences Corporation (EW)

Major holders include Steven Cohen ($160.49 M), Cliff Asness ($132.17 M), Ray Dalio ($24.9 M). According to the latest reported data, 10 tracked investment managers collectively hold approximately 3.95 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $145.55 M, with 3 managers increasing positions and 7 managers reducing holdings.

During the most recent reporting period, 6 managers trimmed their positions, while 1 fully exited EW. The total reported sell value was $155.05 M.

Yes, 0 managers opened new positions in EW, and 3 increased their existing holdings. The total reported buy value was $9.5 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.18% Reduce -2.9% 1,774,120 $160.49 M Q2 2026
0.05% Reduce -25.6% 1,465,185 $132.17 M Q2 2026
0.10% Add 60.1% 275,279 $24.9 M Q2 2026
3.08% Reduce -3.4% 165,208 $14.94 M Q2 2026
0.02% Reduce -56.4% 100,271 $9.07 M Q2 2026
0.00% Reduce -33.6% 87,769 $7.94 M Q2 2026
0.02% Add 73.3% 44,351 $3.55 M Q1 2026
0.00% Reduce -27.6% 21,000 $1.9 M Q2 2026
0.00% Add 8.5% 20,664 $1.87 M Q2 2026
0.00% Add 28.9% 67 $6,109 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form